 |
3,5,3′-triiodothyroacetate |
|---|---|
| Trade Name | |
| Orphan Indication | Well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland |
| USA Market Approval | USA |
| USA Designation Date | 2000-09-20 00:00:00 |
| Sponsor | Elliot Danforth, Jr., M.D.;University of Vermont, 84 Beartown Road;Underhill, Vermont, 05489 |
